BeiGene, Ltd. announced that Dr. Margaret Han Dugan, an independent non-executive director of the Company, has been appointed as a member and Chair of the Compensation Committee of the Board of Directors of the Company (the Compensation Committee), with effect from September 13, 2022. The Compensation Committee consists of three members, namely Dr. Margaret Han Dugan, Mr. Ranjeev Krishana and Mr. Qingqing Yi.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
159.4 USD | -5.06% | -7.24% | -12.04% |
21/05 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
14/05 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.04% | 1.76TCr | |
+10.39% | 12TCr | |
+12.69% | 11TCr | |
-4.33% | 2.47TCr | |
-1.89% | 2.2TCr | |
-5.52% | 1.93TCr | |
-39.36% | 1.73TCr | |
+5.80% | 1.4TCr | |
+32.64% | 1.21TCr | |
-31.66% | 776.53Cr |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Beigene, Ltd. Announces Appointment of Member of Compensation Committee